- Home
- Presse & Aktuelles
- Events
- ILEXIUM 2022
ILEXIUM 2022
20 - 21 June 2022
Kameha Grand Bonn, Germany
Registration deadline
13 June 2022
Welcome to ILEXIUM
Live & in-person in Bonn
As the global COVID-19 pandemic hopefully calms down during the next couple of months and gradually allows for more freedom again, also long-desired live congresses with podium speeches, poster presentations and face-to-face meetings are slowly becoming reality again – also ILEXIUM!
Therefore, it is our greatest pleasure to invite you to the upcoming International Low Energy X-ray IORT User Meeting (ILEXIUM) which will take place on 20 - 21 June 2022 in the historical city of Bonn, Germany to address topics concerning intraoperative radiotherapy (IORT) and give the IORT community the possibility to finally meet and socialize face-to-face again. The event is officially hosted by ZEISS and takes place in consideration of the official COVID-19 regulations of the Federal Republic of Germany.

Elena Sperk, MD
University Medical Center Mannheim,
Germany
We are delighted to have you with us to participate in the first post-pandemic ILEXIUM in 2022. This conference has come a long way and yet it has surpassed the various challenges that our health systems have faced over the last two years. This year, it holds two special values: …

Frank A. Giordano, MD
University Hospital Bonn,
Germany
Warm regards, Elena Sperk & Frank A. Giordano (Conference Chairs)… First, it is held as an in-person event after a long period of dry and exhausting video sessions. Second, it is - for the first time - not taking place in Mannheim, but in Bonn, the city of Beethoven and former capital of the Federal Republic of Germany. Please enjoy the live meeting and the great program we have compiled.
Scientific program
Exchange & Inspire
As always, the scientific program of ILEXIUM will provide a wealth of information about intraoperative radiotherapy, ongoing clinical trials and study results, as well as the latest advancements and further developments of IORT. In addition, it is a splendid opportunity to directly learn from your peers and get first-hand experiences about IORT in the clinical practice.
We would like to encourage you to be part of this exciting IORT community and actively contribute to the scientific program with oral presentations and poster sessions. As a special highlight we will sponsor one hotel night including breakfast per person for the first 30 submitted abstracts.
Take your chance, make this event unique & submit your abstract.
Scientific Program
The meeting starts with a warm welcome from the conference chairs, Frank A. Giordano and Elena Sperk, followed by the scientific program which is categorized in various topics and each category is chaired by leading international experts.
Monday, 20 June 2022
Start | End | Program | Chair & Speaker | Institution | |
---|---|---|---|---|---|
1:00 PM |
1:15 PM |
Welcome Reception & Opening Remarks |
Elena Sperk |
University Medical Center Mannheim, Germany |
|
Frank A. Giordano |
University Hospital Bonn, Germany |
||||
1:15 PM |
2:15 PM |
Keynotes: Brain & Spine I |
Henning Kahl |
University Hospital Augsburg, Germany |
|
Udo Obertacke |
University Medical Center Mannheim, Germany |
||||
|
|
Challenges in tumor response assessment in neuro-oncology |
Kevin Petrecca |
McGill University Health Centre, Canada |
|
|
|
INTRAGO past, present & future |
Frank A. Giordano |
University Hospital Bonn, Germany |
|
|
|
Joint session with NOA: ongoing clinical trials from the German Neuro-Oncology Working Group |
Stephanie Combs |
University Medical Center Mannheim, Germany |
|
|
|
IORT for brain metastases: rationale & outcomes |
Christopher P. Cifarelli |
West Virginia University, USA |
|
2:15 PM |
2:45 PM |
Break |
|||
2:45 PM |
4:20 PM |
Session: Breast Cancer |
Ferran Guedea |
Institut Catala d'Oncologia, Spain |
|
Elena Sperk |
University Medical Center Mannheim, Germany |
||||
|
|
Keynote: Breast preservation + IORT or mastectomy: long-term QoL outcomes |
Hans-Christian Kolberg |
Marienhospital Bottrop, Germany |
|
|
|
Institutional experience with IORT as APBI in early breast cancer |
Evelyn Martínez Pérez |
Catalan Institute of Oncology, Spain |
|
|
|
Breast-Q in patients with breast conserving treatment and low-energy intraoperative radiotherapy |
Maria Jesus Pla Farnós |
Hospital Universitari de Bellvitge, Spain |
|
|
|
Development and future of intraoperative radiotherapy based on single institution experiences |
Zaneta Kaniszewska-Dorsz |
Maria Sklodowska-Curie National Research Institute of Oncology, Poland |
|
|
|
Targeted intraoperative radiotherapy for early breast cancer: cosmetic advantages and acute toxicities - a single Institution’s experience |
Slavyana Usheva |
University Hospital Queen Joanna - ISUL, Bulgaria |
|
|
|
Long-term outcomes of an international cooperative study of intraoperative radiotherapy upfront boost with low energy X-rays in breast cancer |
Gustavo R. Sarria |
University Hospital Bonn, Germany |
|
|
|
Intraoperative radiotherapy in patients with implanted pacemakers based on single institution experience |
Zaneta Kaniszewska-Dorsz |
Maria Sklodowska-Curie National Research Institute of Oncology, Poland |
|
|
|
Comparison of dose distributions: planning, navigation and considering actual applicator position |
César Frenando Vivo de Catarina |
Universidad de Las Palmas de Gran Canaria, Spain |
|
|
|
Intraoperative radiotherapy experience at Clinica Leopoldo Aguerrevere, Caracas-Venezuela |
Alecia Cosson |
Clínica Leopoldo Aguerrevere, Venezuela |
|
4:20 PM |
4:50 PM |
Coffee Break |
|||
4:50 PM |
5:20 PM |
Keynotes: Radiation Biology of IORT |
Gustavo J. Sarria Bardales |
AUNA Oncosalud Clinic, Peru |
|
Gustavo R. Sarria |
University Hospital Bonn, Germany |
||||
|
|
Intraoperative tumor-bed irradiation and immune effects of high radiation doses |
Carsten Herskind |
University Medical Center Mannheim, Germany |
|
|
|
Modifications induced by radiation in tumor bed microenvironment |
Pedro Lara |
San Roque University Hospital, Spain |
|
5:20 PM |
5:30 PM |
Closing Remarks |
Elena Sperk |
University Medical Center Mannheim, Germany |
|
Frank A. Giordano |
University Hospital Bonn, Germany |
||||
5:30 PM |
6:30 PM |
Break |
|||
6:30 PM |
9:30 PM |
The Emami Reception Lecture |
Bahman Emami |
Loyola University Medical Center, USA |
Tuesday, 21 June 2022
Start |
End |
Program |
Chair & Speaker |
Institution |
9:00 AM |
9:05 AM |
Opening Remarks on Day 2 |
Elena Sperk |
University Medical Center Mannheim, Germany |
Frank A. Giordano |
University Hospital Bonn, Germany |
|||
9:05 AM |
9:45 AM |
Keynotes: IORT for Breast Cancer |
Frederik Wenz |
University Medical Center Freiburg, Germany |
Bahman Emami |
Loyola University Medical Center, USA |
|||
|
|
TARGIT IORT during lumpectomy for breast cancer: long-term detailed results from the TARGIT-A trial and update about TARGIT-B trial |
Jayant S. Vaidya |
University College London, United Kingdom |
|
|
Insights into TARGIT-C, -E and -BQR |
Elena Sperk |
University Medical Center Mannheim, Germany |
9:45 AM |
10:15 AM |
Coffee Break |
||
10:15 AM |
11:20 AM |
Session: Brain and Spine II |
Gustavo R. Sarria |
University Hospital Bonn, Germany |
Douglas Guedes |
Hospital Alemão Oswaldo Cruz, Brazil |
|||
|
|
Keynote: Technical considerations for BrainMet IORT: Surgeon's perspective |
Bernhard Meyer |
Technical University Munich, Germany |
|
|
Keynote: Special cases in IORT for brain metastases |
Ehab Shiban |
University Hospital Augsburg, Germany |
|
|
Keynote: Kypho-IORT as a treatment option for spinal metastases |
Frederic Bludau |
University Medical Center Mannheim, Germany |
|
|
Two unusual intraoperative radiation therapy cases: treatment of brain metastasis for pregnant patient and simultaneous treatment of two brain metastases |
Kynann Putra Aninditha |
Klinikum Stuttgart, Germany |
|
|
Dosimetric comparison of upfront boosting with stereotactic radiosurgery versus intraoperative radiotherapy for glioblastoma |
Gustavo R. Sarria |
University Hospital Bonn, Germany |
11:20 AM |
12:05 PM |
Keynotes: Clinical Trials on IORT for Brain Metastases |
Stephanie Combs |
Technical University Munich, Germany |
Kevin Petrecca |
McGill University Health Centre, Canada |
|||
|
|
Prospective clinical trial on IORT for brain metastases in Brazil |
Douglas Guedes |
Hospital Alemao Oswaldo Cruz, Brazil |
|
|
IORT after surgical resection of brain metastases: a phase II clinical study |
Miquel Macia |
Institut Catala d'Oncologia, Spain |
|
|
INTRAMET |
Stefanie Brehmer |
University Medical Center Mannheim, Germany |
12:05 PM |
1:30 PM |
Lunch Break |
||
1:30 PM |
2:40 PM |
Session: Gastrointestinal, Head & Neck, Sarcoma |
Christopher Schmeel |
University Hospital Bonn, Germany |
Davide Scafa |
University Hospital Bonn, Germany |
|||
|
|
Keynote: IORT for head & neck tumors |
Bahman Emami |
Loyola University Medical Center, USA |
|
|
Keynote: Immune response & phase II clinical trial for pancreas cancer |
Joon Seong Park |
Gangnam Severance Hospital, South Korea |
|
|
IORT in pelvic disease: the experience of the European Institute of Oncology |
Roberta Lazzari |
European Institute of Oncology, Italy |
|
|
IORT for pancreatic tumors: rationale and first clinical experiences |
Gustavo J. Sarria |
AUNA Oncosalud Clinic, Peru |
|
|
Intraoperative radiotherapy with photons for pelvic tumors |
Amalia Palacios-Eito |
Reina Sofia University Hospital, Spain |
|
|
Intraoperative radiotherapy safety and efficacy in treatment of locally advanced laryngeal cancer |
Yining Yang |
Tianjin First Central Hospital, China |
2:40 PM |
3:10 PM |
Coffee Break |
||
3:10 PM |
3:55 PM |
Session: Physics & Biology |
Frank Schneider |
University Medical Center Mannheim, Germany |
Stephan Garbe |
University Hospital Bonn, Germany |
|||
|
|
Keynote: Treatment planning in IORT |
Frank Schneider |
University Medical Center Mannheim, Germany |
|
|
X-ray source navigation using optical tracking - a feasibility study |
Sarah Fremgen |
University Medical Center Mannheim, Germany |
|
|
Effect of dosimetry formalism on dose to organs at risk in intraoperative radiotherapy of glioblastoma |
Peter Watson |
McGill University Health Centre, Canada |
|
|
Dosimetric comparison of intraoperative radiotherapy and SRS for liver metastases |
Davide Scafa |
University Hospital Bonn, Germany |
3:55 PM |
4:00 PM |
Closing Remarks & Goodbye |
Elena Sperk |
University Medical Center Mannheim, Germany |
Frank Giordano |
University Hospital Bonn, Germany |
Following the main program, we would like to invite you to an evening reception at the Kameha Grand Bonn with further scientific program. Be excited – another highlight awaits you.
Abstract Submission
Abstract submission for ILEXIUM will take place via a dedicated abstract submission portal for which you will get the respective link after your successful event registration.
- Register yourself via the form below.
- Receive a confirmation email after successful registration.
- Click on the link in the confirmation email.
- Submit your abstract in the abstract submission portal.
The deadline to submit your abstract has been extended again – latest deadline is 06 June 2022. Afterwards the abstract submission for ILEXIUM is closed.
All submitted abstracts will be reviewed and evaluated by the scientific committee for oral presentations or poster sessions. You will receive the corresponding notification via email directly from the scientific committee by end of May 2022.
Abstract guidelines
An abstract is an outline/brief summary of your paper and your whole project. Abstracts must include sufficient information for reviewers to judge the nature and significance of the topic, the adequacy of the investigative strategy, the nature of the results, and the conclusions.
Basis format for abstract:
- Abstract titles should be short (length no more than 12 words), but descriptive. informative titles, indicating key points are encouraged. Abbreviations should not be used in the title.
- Keywords should be provided (between 5-10 words), written in lowercase letters (not applicable to names/scientific names) and should be separated with commas.
- It should be one column of text with a limit of maximum 350 words (minimum 250 words). Acronyms should be written in full the first time, mentioned in the text, followed by the abbreviation in parentheses.
- Please do not include subheadings, bullets, lists and header/footer in the abstract.
- Always follow SI units.
- Scientific names must be in Italic.
- There shall be no citations or references in the abstract specifically. If there is a need to cite references, please provide the sources in brackets.
Font:
Title: Times New Roman, 12 points, Upper case, centered text in bold
Body: Times New Roman, 11 points, Line spacing: 1, one column of text
Authors:
Please double check that the names of author(s) and their affiliation(s) are correctly spelled and formatted, with appropriate capitalization and punctuation. Names and affiliations cannot be edited by the submitter once submitted, and will be published exactly as indicated.
Affiliations:
Affiliations should be indicated with superscript Arabic numbers appearing at the end of surname/family name.
Abstract Evaluation Criteria
- Does the abstract title describe the subject being written about?
- Does the abstract capture the interest of a potential reader of the paper?
- Is the abstract well written in terms of language, grammar, etc.?
- Does the abstract engage the reader by telling her/him what the paper is about and why they should read it?
- Does the abstract make a clear statement of the topic of the paper and the research question?
- Does the abstract say how the research was/is being undertaken?
- Does the abstract indicate the value of the findings and to whom they will be of use?
- Does the abstract describe the work to be discussed in the paper?
- Does the abstract give a concise summary of the findings?
- Does the abstract conform to the word limit of 350 words?
- Does the abstract have between 5 and 10 keywords or phrases that closely reflect the content of the paper?
- Should the abstract be accepted?
Your stay in Bonn
Fascinating & Impressive
Bonn, known as the former capital of the Federal Republic of Germany, is located in the beautiful Central Rhine Valley and fascinates with its impressive building monuments and landmarks. It is the birthplace of Ludwig van Beethoven who is one of the most famous composers of the last centuries. Beside the congress, take your time and enjoy the city of Bonn – it is definitely worth exploring.
How to get to ILEXIUM
Venue
Kameha Grand Bonn
Am Bonner Bogen 1
53227 Bonn
Germany
There is no specific shuttle service. Please use public transportation or take a cab for your travels.
Hotel reservation
For your stay in Bonn, several hotels are available in the surroundings of the venue. We kindly ask you to personally reserve your accommodations.
A limited hotel room contingent is available at the hotels below until four weeks before the event. If you are interested in one of these hotels, please make your reservation directly at the hotel via email and use the reservation code from your registration confirmation email. Please note that the reservation code is not valid for booking portals.
Maritim Hotel Bonn
Godesberger Allee
53111 Bonn, Germany
Reservierung .bonn @maritim .de
Go to website
Hotel Bonn City
Am Marthashof 1
53111 Bonn, Germany
in fo @hotelbonncity .de
Go to website
IntercityHotel Bonn
Quantiusstraße 22
53111 Bonn, Germany
Reservations .bonn @intercityhotel .com
Go to website
AMERON Bonn Hotel Königshof
Adenauerallee 9
53111 Bonn, Germany
Reserv ierung @hotel -koenigshof -bonn .de
Go to website
Hilton Bonn
Berliner Freiheit 2
53111 Bonn, Germany
Reservations .bonn @hilton .com
Go to website
There will be no coverage for additional associated costs such as hotel, transfer, parking or any additional expenses for family and spouses by the event organizer.
Registration closed!
1 I hereby give Carl Zeiss Meditec AG, Göschwitzer Str. 51-52, 07745 Jena, Germany and related companies in accordance with Sections 15ff. German Stock Corporation Act (AktG), ("ZEISS") my permission to disseminate and publish the image(s)/films in which I appear (my "LIKENESS") in course of my participation of ILEXIUM which takes place on June, 20 & 21, 2022 in Bonn, Germany, including for purposes of corporate advertising and the promotion of goods or services. My permission shall apply to all media (e.g. ZEISS homepage, Intranet and social media pages, printed materials such as product brochures etc.) with the exception of television and cinema. It shall also include digitization and editing (e.g. montage or retouching) of the LIKENESS, provided my legitimate interests are not violated. ZEISS shall be entitled to sublicense the contractual rights of use pertaining to the LIKENESS to operators of internet platforms as social media platforms, to use the LIKENESS there as per the particular terms and conditions of the operators. This grant of rights is valid for 2 years from the date of the signing and expires thereafter. This consent is given free of charge.
To all participants for whom “Sunshine” applies: in accordance with the Open Payments (“Sunshine”) provision of the Patient Protection and Affordable Care Act (and similar state laws), the value of food and beverage is subject to public disclosure, and therefore will be reported in compliance with all applicable laws. State of Vermont HCPS: This event was sponsored by Carl Zeiss Meditec AG. Partaking of the food and beverages is prohibited under Vermont’s Gift Ban.